Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy

Development

Volumn 131, Issue 10, 2004, Pages 2485-2496

  Nath, Anjali K ^a   Enciso, Josephine ^b   Kuniyasu, Misako ^a   Hao, Xiao Ying ^a   Madri, Joseph A ^a   Pinter, Emese ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hyperglycemia; Mouse; Nitric oxide; Reactive oxygen species; Vasculogenesis; Yolk sac

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO GROWTH; ENDODERM; GENE EXPRESSION REGULATION; GENETIC MANIPULATION; HYPERGLYCEMIA; IN VITRO STUDY; LETHALITY; MODULATION; MOUSE; NIDATION; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE; YOLK SAC;

ANIMALS; BLASTOCYST; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GLUCOSE; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PREGNANCY; YOLK SAC;

ANIMALIA; MURINAE;

EID: 3042758484     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01131     Document Type: Article

References (121)

1. Adini, I., Rabinovitz, I., Sun, J. F., Prendergast, G. C. and Benjamin, L. E. (2003). RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev. 17, 2721-2732.
2. Antin, P. B., Taylor, R. G. and Yatskievych, T. (1994). Precardiac mesoderm is specified during gastrulation in quail. Dev. Dyn. 200, 144-154.
3. Barroso, R. P., Osuamkpe, C., Nagamani, M. and Yallampalli, C. (1998). Nitric oxide inhibits development of embryos and implantation in mice. Mol. Hum. Reprod. 4, 503-507.
4. Belaoussoff, M., Farrington, S. M. and Baron, M. H. (1998). Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo. Development 125, 5009-5018.
5. Bielinska, M., Narita, N., Heikinheimo, M., Porter, S. B. and Wilson, D. B. (1996). Erythropoiesis and vasculogenesis in embryoid bodies lacking visceral yolk sac endoderm. Blood 88, 3720-3730.
6. Biswas, S., Kabir, S. N. and Pal, A. K. (1998). The role of nitric oxide in the process of implantation in rats. J. Reprod. Fertil. 114, 157-161.
7. Bogdan, C. (2001). Nitric oxide and the regulation of gene expression. Trends Cell Biol. 11, 66-75.
8. Boucher, D. M. and Pedersen, R. A. (1996). Induction and differentiation of extra-embryonic mesoderm in the mouse. Reprod. Fertil. Dev. 8, 765-777.
9. Brent, R. L., Johnson, A. J. and Jensen, M. (1971). The production of congenital malformations using tissue antisera. VII. Yolk-sac antiserum. Teratology 4, 255-275.
10. Brodsky, S. V., Morrishow, A. M., Dharia, N., Gross, S. S. and Goligorsky, M. S. (2001). Glucose scavenging of nitric oxide. Am. J. Physiol. Renal Physiol. 280, F480-F486.
11. Burdon, R. H. (1996). Control of cell proliferation by reactive oxygen species. Biochem. Soc. Trans. 24, 1028-1032.
12. Cha, M. S, Lee, M. J., Je, G. H. and Kwak, J. Y. (2001). Endogenous production of nitric oxide by vascular endothelial growth factor downregulates proliferation of choriocarcinoma cells. Biochem. Biophys. Res. Commun. 282, 1061-1066.
13. Chang, J., Rao, N. V., Markewitz, B. A., Hoidal, J. R. and Michael, J. R. (1996). Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury. Am. J. Physiol. 270, L931-L940.
14. Channon, K. M. and Guzik, T. J. (2002). Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J. Physiol. Pharmacol. 53, 515-524.
15. Chen, L. T. and Hsu, Y. C. (1982). Development of mouse embryos in vitro: preimplantation to the limb bud stage. Science 218, 66-68.
16. Chiarugi, P. (2001). The redox regulation of LMW-PTP during cell proliferation or growth inhibition. IUBMB Life 52, 55-59.
17. Cockroft, D. L. and Coppola, P. T. (1977). Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratol. 16, 141-146.
18. Connelly, L., Jacobs, A. T., Palacios-Callender, M., Moncada, S. and Hobbs, A. J. (2003). Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J. Biol. Chem. 278, 26480-26487.
19. Damert, A., Miquerol, L., Gertsenstein, M., Risau, W. and Nagy, A. (2002). Insufficient VEGF-A activity in the yolk sac endoderm compromises hematopoietic and endothelial differentiation. Development 129, 1881-1892.
20. Darland, D. C. and D'Amore, P. A. (2001). Cell-cell interactions in vascular development. Curr. Top. Dev. Biol. 5, 107-149.
21. Didion, S. P., Ryan, M. J., Didion, L. A., Fegan, P. E., Sigmund, C. D. and Faraci, F. M. (2002). Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ. Res. 91, 938-944.
22. Downs, K. M. and Davies, T. (1993). Staging of gastrulating mouse embryos by morphological landmarks in the dissecting microscope. Development 118, 1255-1266.
23. Dulak, J. and Jozkowicz, A. (2003). Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antiox. Redox Signal. 5, 123-132.
24. Duncan, G. S., Andrew, D. P., Takimoto, H., Kaufman, S. A., Yoshida, H., Spellberg, J., Luis de la Pompa, J., Elia, A., Wakeham, A., Karan-Tamir, B., Muller, W. A. et al. (1999). Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162, 3022-3030.
25. Dyer, M. A., Farrington, S. M., Mohn, D., Munday, J. R. and Barm, M. H. (2001). Indian hedgehog activates hematopoiesis and vasculogenesis and can specify prospective neuroectodermal cell fate in the mouse embryo. Development 128, 1717-1730.
26. Eriksson, U. J. and Borg, L. A. (1991). Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia. 34, 325-331.
27. Eriksson, U. J. and Borg, L. A. (1993). Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42, 411-419.
28. Farrington, S. M., Belaoussoff, M. and Baron, M. H. (1997). Winged-helix, Hedgehog and Bmp genes are differentially expressed in distinct cell layers of the murine yolk sac. Mech. Dev. 62, 197-211.
29. Flamme, I., Frolich, T. and Risau, W. (1997). Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell Physiol. 173, 206-210.
30. Folkman, J. and D'Amore, P. A. (1996). Blood vessel formation: what is its molecular basis? Cell 87, 1153-1155.
31. Freeman, S. J., Beck, F. and Lloyd, J. B. (1981). The role of the visceral yolk sac in mediating protein utilization by rat embryos cultured in vitro. J. Embryol. Exp. Morphol. 66, 223-234.
32. Freinkel, N., Cockroft, D. L., Lewis, N. J., Gorman, L., Akazawa, S., Phillips, L. S. and Shambaugh, G. E., 3rd (1986). Fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture. Am. J. Clin. Nutr. 44, 986-995.
33. Fulton, D., Gratton, J. P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A. and Sessa, W. C. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601.
34. Gagioti, S., Scavone, C. and Bevilacqua, E. (2000). Participation of the mouse implanting trophoblast in nitric oxide production during pregnancy. Biol. Reprod. 62, 260-268.
35. Gerber, H. P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G. A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M. and Ferrara, N. (1999). VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159.
36. Gerety, S. S. and Anderson, D. J. (2002). Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development. 129, 1397-1410.
37. Gewaltig, M. T. and Kojda, G. (2002). Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc. Res. 55, 250-260.
38. Giaccia, A. J. and Kastan, M. B. (1998). The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983.
39. Gouge, R. C., Marshburn, P., Gordon, B. E., Nunley, W. and Huet-Hudson, Y. M. (1998). Nitric oxide as a regulator of embryonic development. Biol. Reprod. 58, 875-879.
40. Hagay, Z. J., Weiss, Y., Zusman, I., Peled-Kamar, M., Reece, E. A., Eriksson, U. J. and Groner, Y. (1995). Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am. J. Obstet. Gynecol. 173, 1036-1041.
41. Hermann, C., Zeiher, A. M. and Dimmeler, S. (1997). Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 17, 3588-3592.
42. Hibbs, J. B., Jr, Taintor, R. R., Vavrin, Z. and Rachlin, E. M. (1989). Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157, 87-94.
43. Huang, L., Sankar, S., Lin, C., Kontos, C. D., Schroff, A. D., Cha, E. H., Feng, S. M., Li, S. F., Yu, Z., van Etten, R. L., Blanar, M. A. and Peters, K. G. (1999a). HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J. Biol. Chem. 274, 38183-38188.
44. Huang, L. E., Willmore, W. G., Gu, J., Goldberg, M. A. and Bunn, H. F. (1999b). Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J. Biol. Chem. 274, 9038-9044.
45. Huie, R. E. and Padmajas, S. (1993). The reaction of NO with superoxide. Free Radic. Res. Commun. 18, 195-199.
46. Hunter, E. S. and Sadler, T. W. (1992). The role of the visceral yolk sac in hyperglycemia-induced embryopathies in mouse embryos in vitro. Teratology 45, 195-203.
47. Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Ficher, E., Younkin, S., Borchelt, D. R., Hsiao, K. K. and Carlson, G. A. (1999). SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2, 157-161.
48. Jablonka-Shariff, A. and Olson, L. M. (1998). The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 139, 2944-2954.
49. Jollie, W. P. (1990). Development, morphology and function of the yolk-sac placenta of laboratory rodents. Teratology 41, 361-381.
50. Joshi, M. S., Ponthier, J. L. and Lancaster, J. R., Jr (1999). Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Rad. Biol. Med. 27, 1357-1366.
51. Jugdutt, B. I. (2002). Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail. Rev. 7, 391-405.
52. Kim, H., Shim, J., Han, P. L. and Choi, E. J. (1997). Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase. J. Biochem. 36, 13677-13681.
53. Kim, Y. M., Bergonia, H. and Lancaster, J. R., Jr (1995). Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett. 374, 228-232.
54. Kroncke, K. D. and Carlberg, C. (2000). Inactivation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide. FASEB J. 14, 166-173.
55. Kojima, H., Nakatsubo, N., Kikuchi, K., Kawahara, S., Kirino, Y., Nagoshi, H., Hirata, Y. and Nagano, T. (1998a). Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70, 2446-2453.
56. Kojima, H., Sakurai, K., Kikuchi, K., Kawahara, S., Kirino, Y., Nagoshi, H., Hirata, Y. and Nagano, T. (1998b). Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem. Pharm. Bull. 46, 373-375.
57. Kojima, H., Urano, Y., Kikuchi, K., Higuchi, T., Hirata, Y. and Nagano, T. (1999). Fluorescent indicators for imaging nitric oxide production. Angew. Chem. Int. Ed. Eng. 38, 3209-3212.
58. Koppenol, W. H. (1998). The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic. Biol. Med. 25, 385-391.
59. Kroncke, K. D., Fehsel, K. and Kolb-Bachofen, V. (1997). Inhibition of angiogenesis, cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide 1, 107-120.
60. Lancaster, J. R. (1994). Simulation of the diffusion and reaction of endogeneously produced nitric oxide. Proc. Natl. Acad. Sci. USA 91, 8137-8141.
61. Lander, H. M. (1997). An essential role for free radicals and derived species signal transduction. FASEB J. 11, 118-124.
62. Lerman, S., Roszalka, T. R., Jensen, M., Andrew, C. L., Beckman, D. A. and Brent, R. L. (1986). In vitro studies on the effect of yolk sac antisera on functions of the visceral yolk sac: I. Pinocytosis and transport of small molecules. Teratology 34, 335-341.
63. Limbourg, F. P., Huang, Z., Plumier, J. C., Simoncini, T., Fujioka, M., Tuckermann, J., Schütz, G., Moskowitz, M. A. and Liao, J. K. (2002). Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest. 110, 1729-1738.
64. Malinski, T. and Taha, Z. (1992). Nitric oxide release from a single cell measured by a porphyrinic-based microsensor. Nature 358, 676-678.
65. Malinski, T., Bailey, F., Zhang, Z. G. and Chopp, M. (1993a). Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13, 355-358.
66. Malinski, T., Taha, Z., Grunfeld, S., Patton, S., Kapturczak, M. and Tomboulian, P. (1993b). Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem. Biophys. Res. Commun. 193, 1079-1082.
67. Matthews, J. R., Botting, C. H., Panico, M., Morris, H. R. and Hay, R. T. (1996). Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 24, 2236-2242.
68. Maul, H., Longo, M., Saade, G. R. and Garfield, R. E. (2003). Nitric oxide and its role during pregnancy: from ovulation to delivery. Curr. Pharm. Des. 9, 359-380.
69. Maulik, N. (2002). Redox signaling of angiogenesis. Antioxid. Redox Signal. 4, 805-815.
70. Mayhan, W. G. (1997). Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain Res. 760, 204-209.
71. Meulemans, A. (1994). Diffusion coefficients and half-lives of nitric oxide and N-nitroso-L-arginine in rat cortex. Neurosci. Lett. 171, 89-93.
72. Meyer, M., Pahl, H. L. and Baeuerle, P. A. (1994). Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem. Biol. Interact. 91, 91-100.
73. Michell, B. J., Griffiths, J. E., Mitchelhill, K. I., Rodriguez-Crespo, I., Tiganis, T., Bozinovski, S., de Montellano, P. R., Kemp, B. E. and Pearson, R. B. (1999). The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 12, 845-849.
74. Mills, J. L., Baker, L. and Goldman, A. S. (1979). Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28, 292-293.
75. Minor, R. L., Myers, J. R., Guerra, P. R., Bates, J. N. and Harrison, D. G. (1990). Diet-induced atheroscelerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86, 2109-2116.
76. Miura, Y. and Wilt, F. H. (1969). Tissue interaction and the formation of the first erythroblasts of the chick embryo. Dev. Biol. 19, 201-211.
77. Moncada, S., Palmer, R. M. J. and Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
78. Mügge, A., Elwell, J. H., Peterson, T. E., Hofmeyer, T. G., Heistad, D. D. and Harrison, D. G. (1991). Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 69, 1293-1300.
79. New, D. A. T., Coppola, P. T. and Cockroft, D. L. (1976). Comparison of growth in vitro and in vivo of post-imploantation rat embryos. J. Embryol. Exp. Morphol. 36, 133-140.
80. New, D. A. (1978). Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. 53, 81-122.
81. New, D. A. T. (1991). The culture of postimplantation embryos. Hum. Reprod. 6, 58-63.
82. Nose, K. (2000). Role of reactive oxygen species in the regulation of physiological functions. Biol. Pharm. Bull. 23, 897-903.
83. Novaro, V., Gonzalez, E. and Jawerbaum, A. (1997). Nitric oxide synthase regulation during embryonic implantation. Reprod. Fertil. Dev. 9, 557-564.
84. Palis, J., McGrath, K. E. and Kingsley, P. D. (1995). Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. Blood 86, 156-163.
85. Papapetropoulos, A., Rudic, R. D. and Sessa, W. C. (1999). Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc. Res. 43, 509-520.
86. Paxinou, E., Weisse, M., Chen, Q., Souza, J. M., Hertkorn, C., Selak, M., Daikhin, E., Yudkoff, M., Sowa, G., Sessa, W. C. and Ischiropoulos, H. (2001). Dynamic regulation of metabolism and respiration by endogenously produced nitric oxide protects against oxidative stress. Proc. Natl. Acad. Sci. USA 98, 11575-11580.
87. Pinter, E., Reece, E. A., Leranth, C. Z., Sanyal, M. K., Hovvins, J. C., Mahoney, M. J. and Naftolin, F. (1986). Yolk sac failure in embryopathy due to hyperglycemia: ultra structural analysis of yolk sac differentiation associated with embryopahty in rat conceptuses under hyperglycemic conditions. Teratology 33, 73-84.
88. Pinter, E., Mahooti, S., Wang, Y., Imhof, B. A. and Madri, J. A. (1999). Hyperglycemia-induced vasculopathy in the murine vitelline vasculature. Am. J. Path. 154, 1367-1379.
89. Purcell, T. L., Given, R., Chwalisz, K. and Garfield, R. E. (1999). Nitric oxide synthase distribution during implantation in the mouse. Mol. Hum. Reprod. 5, 467-475.
90. Rashbass, P. and Ellington, S. K. (1988). Development of rat embryos cultured in serum prepared from rats with streptozotocin-induced diabetes. Teratology 37, 51-61.
91. Reece, E. A., Pinter, E., Leranth, C., Hobbins, J. C., Mahoney, M. J. and Naftolin, F. (1989). Yolk sac failure in embryopathy due to hyperglycemia: horseradish peroxidase uptake in the assessment of yolk sac function. Obstet. Gynecol. 74, 755-762.
92. Reece, E. A., Pinter, E., Homko, C., Wu, Y. K. and Naftolin, F. (1994). The yolk sac theory: closing the circle on why diabetes-associated malformations occur. J. Soc. Gynecol. Invest. 1, 3-13.
93. Reece, E. A., Wiznitzer, A., Homko, C. J., Hagay, Z. and Wu, Y. K. (1996). Synchronization of the factors critical for diabetetic teratogenesis: An in vitro model. Am. J. Obstet. Gynecol. 174, 1281-1284.
94. Risau, W. and Flamme, I. (1995). Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91.
95. Sadler, T. W. (1979). Culture of early somite mouse embryos during organogenesis. J. Embryol. Exp. Morphol. 49, 17-25.
96. Sadler, T. W. (1980a). Effects of maternal diabetes on early embryogenesis: I. The teratogenic potential of diabetic serum. Teratology 21, 339-347.
97. Sadler, T. W. (1980b). Effects of maternal diabetes on early embryogenesis: II. Hyperglycemia-induced exencephaly. Teratology 21, 349-356.
98. Sadler, T. W. and Warner, C. W. (1984). Use of whole embryo culture for evaluating toxicity and teratogenicity. Pharmacol. Rev. 36, 145S-150S.
99. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
100. Schmidt, H. H. and Walter, U. (1994). NO at work. Cell 78, 919-925.
101. Sengoku, K., Takuma, N., Horikawa, M., Tsuchiya, K., Komori, H., Sharifa, D., Tamate, K. and Ishikawa, M. (2001). Requirement of nitric oxide for murine oocyte maturation, embryo development, and trophoblast outgrowth in vitro. Mol. Reprod. Dev. 58, 262-268.
102. Shaul, P. W. (2002). Regulation of endothelial nitric oxide synthase: location, location, location. Annu. Rev. Physiol. 64, 749-774.
103. Shukovski, L. and Tsafriri, T. (1995). The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 135, 2287-2290.
104. So, H. S., Park, R. K., Kim, M. S., Lee, S. R., Jung, B. H., Chung, S. Y., Jun, C. D. and Chung, H. T. (1998). Nitric oxide inhibits c-Jun N-terminal kinase 2 (JNK2) via S-nitrosylation. Biochem. Biophys. Res. Commun. 247, 809-813.
105. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
106. Tabuchi, A., Oh, E., Taoka, A., Sakurai, H., Tsuchiya, T. and Tsuda, M. (1996). Rapid attenuation of AP-1 transcriptional factors associated with nitric oxide (NO)-mediated neuronal cell death. J. Biol. Chem. 271, 31061-31067.
107. Tallquist, M. D., Soriano, P. and Klinghoffer, R. A. (1999). Growth factor signaling pathways in vascular development. Oncogene 18, 7917-7932.
108. Telfer, J. E., Norman, J. E. and Cameron, I. T. (1995). Identification of nitric oxide synthase in human uterus. Hum. Reprod. 10, 19-23.
109. Torres, M. and Forman, H. J. (2000). Nitric oxide, oxidative stress, and signal transduction. In Nitric Oxide: Biology and Pathobiology (ed. L. J. Ignarro), pp. 329-342. San Diego: Academic Press.
110. Urbich, C., Dernbach, E., Aicher, A., Zeiher, A. M. and Dimmeler, S. (2002). CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106, 981-986.
111. Waddell, W. J. and Marlowe, C. (1990). Biochemical regulation of the accessablitity of teratogens to the developing embryo. In The Biochemical Basis of Chemical Teratogenesis (ed. M. R. Junchaee), pp. 1-62. North Holland: Elsevier.
112. Wentzel, P. and Eriksson, U. J. (1998). Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 47, 677-684.
113. Wilt, F. H. (1965). Erythropoiesis in the chick embryo: the role of endoderm. Science 147, 1588-1590.
114. Wink, D. A., Hanbauer, I., Krishna, M., DeGraff, W., Gamson, J. and Mitchell, J. B. (1993). Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90, 9813-9817.
115. Wink, D. A. and Mitchell, J. B. (1998). Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25, 434-456.
116. Wise, D. L. and Houghton, G. (1969). Solubilities and diffusivities of oxygen in hemolyzed human blood solutions. Biophys. J. 9, 36-53.
117. Wood, J. and Garthwaite, J. (1994). Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signaling and its pharmacological properties. Neuropharmacology 33, 1235-1244.
118. Yasuda, Y., Nishi, N., Takahashi, J. A., Konishi, H., Ohara, I., Fujita, H., Ohta, M., Itoh, N., Hatanaka, M. and Tanimura, T. (1992). Induction of avascular yolk sac due to reduction of basic fibroblast growth factor by retinoic acid in mice. Dev. Biol. 150, 397-413.
119. Zhang, D. X., Zou, A. P. and Li, P. L. (2001). Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries. Circ. Res. 88, 824-831.
120. Zhang, J., Schmidt, J., Ryschich, E., Mueller-Schilling, M., Schumacher, H. and Allenberg, J. R. (2003). Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J. Vasc. Surg. 38, 360-367.
121. Zusman, I., Yaffe, P. and Ornoy, A. (1987). The effects of high-sucrose diets and of maternal diabetes on the ultrastructure of the visceral yolk sac endoderm in rat embryos developing in vivo and in vitro. Acta Anat. 128, 11-18.